Moderna, Inc. (MRNA)
200.10
-2.53
(-1.25%)
USD |
NASDAQ |
Oct 23, 16:00
201.23
+1.13
(+0.56%)
After-Hours: 20:00
Moderna Enterprise Value : 75.99B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 75.99B |
| October 22, 2026 | 77.00B |
| October 21, 2026 | 94.23B |
| October 20, 2026 | 92.74B |
| October 19, 2026 | 86.68B |
| October 16, 2026 | 83.13B |
| October 15, 2026 | 90.51B |
| October 14, 2026 | 86.44B |
| October 13, 2026 | 82.43B |
| October 12, 2026 | 81.43B |
| October 09, 2026 | 85.92B |
| October 08, 2026 | 74.75B |
| October 07, 2026 | 74.54B |
| October 06, 2026 | 70.95B |
| October 05, 2026 | 77.23B |
| October 02, 2026 | 71.96B |
| October 01, 2026 | 71.54B |
| September 30, 2026 | 72.98B |
| September 29, 2026 | 77.33B |
| September 28, 2026 | 74.86B |
| September 25, 2026 | 75.50B |
| September 24, 2026 | 73.88B |
| September 23, 2026 | 68.81B |
| September 22, 2026 | 68.99B |
| September 21, 2026 | 65.15B |
| Date | Value |
|---|---|
| September 18, 2026 | 57.61B |
| September 17, 2026 | 59.22B |
| September 16, 2026 | 54.25B |
| September 15, 2026 | 53.51B |
| September 14, 2026 | 54.68B |
| September 11, 2026 | 53.59B |
| September 10, 2026 | 50.66B |
| September 09, 2026 | 50.26B |
| September 08, 2026 | 52.14B |
| September 04, 2026 | 54.22B |
| September 03, 2026 | 55.55B |
| September 02, 2026 | 56.32B |
| September 01, 2026 | 57.70B |
| August 31, 2026 | 52.14B |
| August 28, 2026 | 51.21B |
| August 27, 2026 | 53.11B |
| August 26, 2026 | 55.86B |
| August 25, 2026 | 59.52B |
| August 24, 2026 | 51.57B |
| August 21, 2026 | 54.06B |
| August 20, 2026 | 49.34B |
| August 19, 2026 | 65.73B |
| August 18, 2026 | 21.27B |
| August 17, 2026 | 21.87B |
| August 14, 2026 | 21.41B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Revolution Medicines, Inc. | 37.31B |
| Vaxcyte, Inc. | 7.378B |
| Twist Bioscience Corp. | 8.696B |
| BioNTech SE | 5.602B |
| Vir Biotechnology, Inc. | 1.347B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -782.00M |
| Revenue (Quarterly) | 145.00M |
| Total Expenses (Quarterly) | 927.00M |
| EPS Diluted (Quarterly) | -1.965 |
| Gross Profit Margin (Quarterly) | -7.59% |
| Profit Margin (Quarterly) | -539.3% |
| Earnings Yield | -3.99% |
| Normalized Earnings Yield | -3.990 |